| P50 | author | Chandraiah Godugu | Q84125640 |
| P2093 | author name string | Swarna Bale | |
| | Pooladanda Venkatesh | |
| | Manoj Sunkoju | |
| P2860 | cites work | TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4 | Q24314661 |
| | TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT) | Q24813751 |
| | Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition | Q26745545 |
| | Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature | Q27004290 |
| | Epithelial-mesenchymal transition: An emerging target in tissue fibrosis | Q28083351 |
| | Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 |
| | Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis | Q28240230 |
| | Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer | Q28383510 |
| | Pulmonary fibrosis: pathogenesis, etiology and regulation | Q28388425 |
| | Withaferin-A reduces type I collagen expression in vitro and inhibits development of myocardial fibrosis in vivo | Q28482173 |
| | Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials | Q28484304 |
| | Determination of collagen content within picrosirius red stained paraffin-embedded tissue sections using fluorescence microscopy | Q30316404 |
| | Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent | Q33730117 |
| | The evolution of extracellular matrix | Q33772478 |
| | TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway | Q33890533 |
| | Retracted: Inhibition of HMGB1-Induced Angiogenesis by Cilostazol via SIRT1 Activation in Synovial Fibroblasts from Rheumatoid Arthritis | Q34050700 |
| | Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen | Q34101398 |
| | Molecular insight in the multifunctional activities of Withaferin A. | Q34299843 |
| | Anticancer property of gallic acid in A549, a human lung adenocarcinoma cell line, and possible mechanisms | Q34496458 |
| | Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation | Q34527773 |
| | Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells | Q34593997 |
| | TGF-β1 Up-Regulates Connective Tissue Growth Factor Expression in Human Granulosa Cells through Smad and ERK1/2 Signaling Pathways. | Q35587148 |
| | Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model | Q35652062 |
| | The pathogenesis of COPD and IPF: distinct horns of the same devil? | Q35766351 |
| | Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis | Q35800025 |
| | Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation | Q35918710 |
| | phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development | Q35965422 |
| | Withaferin-A Inhibits Colon Cancer Cell Growth by Blocking STAT3 Transcriptional Activity | Q36135798 |
| | Molecular and cellular mechanisms of pulmonary fibrosis | Q36237168 |
| | Determination of nitrite/nitrate in human biological material by the simple Griess reaction. | Q50755203 |
| | Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study. | Q51592084 |
| | Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway. | Q54439156 |
| | Idiopathic pulmonary fibrosis | Q56764887 |
| | The role of neutrophils in the pathogenesis of idiopathic pulmonary fibrosis | Q73876038 |
| | ??? | Q28215495 |
| | CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression | Q36291173 |
| | TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event | Q36844219 |
| | Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. | Q36857862 |
| | The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | Q36970923 |
| | Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor. | Q37089910 |
| | Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells | Q37384594 |
| | Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models | Q37492629 |
| | Oropharyngeal aspiration of bleomycin: An alternative experimental model of pulmonary fibrosis developed in Swiss mice | Q37501950 |
| | Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis | Q37514728 |
| | A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis. | Q37628170 |
| | A mouse model of chronic idiopathic pulmonary fibrosis | Q37664164 |
| | Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis | Q37799183 |
| | Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis | Q37813854 |
| | Angiogenesis in pulmonary fibrosis: too much or not enough? | Q38026412 |
| | The burden of idiopathic pulmonary fibrosis: an unmet public health need. | Q38208148 |
| | TNF-α-induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. | Q38668289 |
| | Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC). | Q38714359 |
| | TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB. | Q38747679 |
| | Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes | Q38844273 |
| | Non-Smad Signaling Pathways of the TGF-β Family | Q39013667 |
| | In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents | Q40134350 |
| | Inhibition of p38 MAPK reduces tumor conditioned medium-induced angiogenesis in co-cultured human umbilical vein endothelial cells and fibroblasts | Q40135944 |
| | Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation. | Q40242079 |
| | Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. | Q40457821 |
| | Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro | Q40487580 |
| | TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins | Q40676876 |
| | The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling | Q40891329 |
| | Withaferin A inhibits the proliferation of gastric cancer cells by inducing G2/M cell cycle arrest and apoptosis | Q40978388 |
| | Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis | Q41010363 |
| | ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology. | Q42031689 |
| | CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells | Q42437301 |
| | Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis | Q42562736 |
| | VEGF levels in pulmonary fibrosis. | Q43058785 |
| | Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation | Q43119866 |
| | Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice | Q43882371 |
| | Differential expression of transforming growth factor-beta type I and II receptors by pulmonary cells in bleomycin-induced lung injury: correlation with repair and fibrosis | Q43950028 |
| | α-Smooth muscle actin-positive myofibroblasts, in association with epithelial-mesenchymal transition and lymphogenesis, is a critical prognostic parameter in patients with oral tongue squamous cell carcinoma | Q44711229 |
| | Lung lymphocytes in bleomycin-induced pulmonary disease | Q45047357 |
| | Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver | Q45053341 |
| | Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKKβ. | Q49050188 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 248 | |
| P577 | publication date | 2018-03-22 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | An Adaptogen: Withaferin A Ameliorates in Vitro and in Vivo Pulmonary Fibrosis by Modulating the Interplay of Fibrotic, Matricelluar Proteins, and Cytokines. | |
| P478 | volume | 9 | |